Thursday, Jan 11, 2024 · SEC filings

What the smart money revealed on Jan 11

Real insider buys11insiders · $30.9M
Real insider sales34insiders · $15.8M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

290 insider filings came in. We hid 49 planned (10b5-1) sellers and 185 people whose filings were routine, like grants and tax withholding.

trending_up

Dyne Therapeutics (DYN) Director Dirk Kersten bought $30M

1.71M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 9
$30M
trending_up

Agree Realty (ADC) Executive Chairman of Board Richard Agree bought $657K

10,500 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 10
$657K
trending_up

MainStay CBRE Global Infrastructure Megatrends Term Fund (MEGI) Director Jacques Perold bought $76.7K

5,700 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 8–9
$76.7K
trending_up

Flat Rock Opportunity Fund (FROPX) CEO Robert Grunewald bought $62K

3,267 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 10
$62K
trending_down

Symbotic (SYM) Senior Vice President Michael Dunn sold $2.99M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 136,822 shares directly.

Real sale Form 4 Traded Jan 9
$2.99M
trending_down

Atlassian (TEAM) Co-CEO Michael Cannon-Brookes sold $2M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 445,014 shares.

Real sale Form 4 Traded Jan 10
$2M
trending_down

Atlassian (TEAM) Co-CEO Scott Farquhar sold $2M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 445,014 shares.

Real sale Form 4 Traded Jan 10
$2M
Show 7 more real buys
Show 31 more real sales
WYNN Wynn Resorts · CEO Craig Billings · Traded Jan 9
$1.09M
AZO AutoZone · Director George Mrkonic Jr. · Traded Jan 9
$1.05M
VEEV Veeva Systems · Chief Marketing Officer Eleni Zuppas · Traded Jan 9
$838K
REPX Riley Exploration Permian · Director Bryan Lawrence · Traded Jan 9–11
$804K
GTLB Gitlab · CFO Brian Robins · Traded Jan 9
$791K
AYI Acuity Brands · SVP and General Counsel Barry Goldman · Traded Jan 10
$429K
CAL Caleres · Chief Information Officer Willis Hill · Traded Jan 9
$422K
WYNN Wynn Resorts · CFO Julie Cameron-Doe · Traded Jan 9
$420K
WYNN Wynn Resorts · EVP and General Counsel Ellen Whittemore · Traded Jan 9
$398K
ABNB Airbnb · CTO Aristotle Balogh · Traded Jan 9
$381K
PCOR Procore Technologies · Director Connor O · Traded Jan 10
$358K
RPM RPM International · VP-Operations Timothy Kinser · Traded Jan 10
$255K
NCNO nCino · Chief Product Officer Matthew Hansen · Traded Jan 9
$206K
BOX Box · VP Chief Acct Ofr and Controller Eli Berkovitch · Traded Jan 9
$193K
FICO Fair Isaac · Executive Vice President and CFO Steven Weber · Traded Jan 9
$158K
DNLI Denali Therapeutics · President and CEO Ryan Watts · Traded Jan 9
$155K
INSM Insmed · CFO Sara Bonstein · Traded Jan 9
$131K
TRMB Trimble · President and CEO Robert Painter · Traded Jan 9
$128K
AMLX Amylyx Pharmaceuticals · Co-CEO Justin Klee · Traded Jan 9
$95.4K
AMLX Amylyx Pharmaceuticals · Co-CEO Joshua Cohen · Traded Jan 9
$95.4K
INSM Insmed · General Counsel Michael Smith · Traded Jan 9
$68.2K
TTI Tetra Technologies · Director Thomas Bates Jr. · Traded Aug 2 · Filed late
$59.9K
INSM Insmed · Chief Commercial Officer John Wise · Traded Jan 9
$53.6K
AMLX Amylyx Pharmaceuticals · Chief Medical Officer Patrick Yeramian · Traded Jan 9
$45.9K
VIRC Virco MFG · Vice President Patricia Quinones · Traded Jan 10
$44.7K
AMLX Amylyx Pharmaceuticals · CFO James Frates · Traded Jan 9
$44.4K
SLDB Solid Biosciences · CFO and Treasurer Kevin Tan · Traded Jan 9
$32.3K
CDMO Avid Bioservices · CFO Daniel Hart · Traded Jan 10
$14.9K
CDMO Avid Bioservices · V. P. Mark Ziebell · Traded Jan 10
$8.3K
CDMO Avid Bioservices · Chief Operations Officer Richard Richieri · Traded Jan 10
$7.23K
CDMO Avid Bioservices · Chief Commercial Officer Matthew Kwietniak · Traded Jan 10
$6.54K

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist